Skip to main content

Table 6 Summary of clinicopathological data of 76 ovarian cancer patients

From: Hypermethylation of the TGF-β target, ABCA1 is associated with poor prognosis in ovarian cancer patients

 

Ovarian cancer ( n  = 76)

Age at diagnosis (years)

 

  Median

54

  Range

18–90

Stage

 

  FIGO (I–II)

27

  FIGO (III–VI)

49

Grade

 

  I

13

  II

16

  III

47

Pathological type

 

  Serous

48

  Mucinous

23

  Endometroid

5

Median survival (months)

 

  PFS

11.51

  OS

17.42

  1. PFS progression-free survival, OS overall survival.
Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us